Literature DB >> 8396465

Advantages of magnetic resonance imaging in breast surgery treatment planning.

T E Merchant1, H Obertop, P W de Graaf.   

Abstract

Preoperative magnetic resonance imaging (MRI) was performed in 40 patients with malignant and benign breast tumors. Images were qualitatively evaluated to determine features of MRI that would benefit breast surgery treatment planning. MRI was found to be exceptional in demonstrating the relationship of tumors with respect to structures such as the chest wall, nipple, and skin. Tumor size was estimated by MRI, mammography, and gross pathological measurement in the 32 patients confirmed to have a malignant tumor of the breast. MRI estimated the tumor size to be larger than mammography in 71% of the cases and larger than pathological measurement in 84% of the cases. Compared with the standard method for determining tumor size (pathological measurement), MRI would have upstaged 22% of the evaluated cases from T1 to T2 and 10% of the cases from T2 to T3. MRI may prove useful in selecting patients for breast conserving therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8396465     DOI: 10.1007/bf00689840

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  MRI appearance of multiple papilloma of the breast.

Authors:  T E Merchant; H C Kievit; D Beijerink; S C van der Putte; P W de Graaf
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

2.  Fibroadenoma of the breast: in vivo magnetic resonance characterization.

Authors:  T E Merchant; P W de Graaf; C W Nieuwenhuizen; H C Kievit; C J Bakker; W Den Otter
Journal:  Eur J Radiol       Date:  1991 Sep-Oct       Impact factor: 3.528

3.  Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants.

Authors:  S H Heywang; T Hilbertz; R Beck; W M Bauer; W Eiermann; W Permanetter
Journal:  J Comput Assist Tomogr       Date:  1990 May-Jun       Impact factor: 1.826

4.  Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes.

Authors:  C C Say; W L Donegan
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

5.  Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons.

Authors:  R Bedwani; J Vana; D Rosner; R L Schmitz; G P Murphy
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

6.  Indicators of prognosis in node-negative breast cancer.

Authors:  H Sigurdsson; B Baldetorp; A Borg; M Dalberg; M Fernö; D Killander; H Olsson
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

7.  Magnetic resonance imaging in the diagnosis of breast disease.

Authors:  N Dash; A R Lupetin; R H Daffner; Z L Deeb; R J Sefczek; R L Schapiro
Journal:  AJR Am J Roentgenol       Date:  1986-01       Impact factor: 3.959

8.  Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.

Authors:  T Nemoto; J Vana; R N Bedwani; H W Baker; F H McGregor; G P Murphy
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

9.  MR imaging of the breast using gadolinium-DTPA.

Authors:  S H Heywang; D Hahn; H Schmidt; I Krischke; W Eiermann; R Bassermann; J Lissner
Journal:  J Comput Assist Tomogr       Date:  1986 Mar-Apr       Impact factor: 1.826

10.  Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.

Authors:  E R Fisher; B Fisher; R Sass; L Wickerham
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

View more
  5 in total

1.  The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.

Authors:  Kaoru Itakura; Juan Lessing; Theadora Sakata; Amy Heinzerling; Eline Vriens; Dorota Wisner; Michael Alvarado; Laura Esserman; Cheryl Ewing; Nola Hylton; E Shelley Hwang
Journal:  Clin Breast Cancer       Date:  2011-03       Impact factor: 3.225

2.  Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography.

Authors:  P L Davis; M J Staiger; K B Harris; M A Ganott; J Klementaviciene; K S McCarty; H Tobon
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer.

Authors:  Yanming Yu; Quan Jiang; Yanwei Miao; Jun Li; Shanglian Bao; Haoyu Wang; Chunxue Wu; Xiaoying Wang; Jiong Zhu; Yi Zhong; E Mark Haacke; Jiani Hu
Journal:  Radiology       Date:  2010-08-16       Impact factor: 11.105

4.  Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate.

Authors:  T H Witney; M I Kettunen; D-e Hu; F A Gallagher; S E Bohndiek; R Napolitano; K M Brindle
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

5.  Imaging in evaluation of response to neoadjuvant breast cancer treatment.

Authors:  L Ollivier; C Balu-Maestro; J Leclère
Journal:  Cancer Imaging       Date:  2005-05-24       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.